Global Small Molecule Anti-tumor Targted Drug Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Small Molecule Anti-tumor Targted Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Small Molecule Anti-tumor Targted Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Anti-tumor Targted Drug market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Small Molecule Anti-tumor Targted Drug, covering the supply chain analysis, impact assessment to the Small Molecule Anti-tumor Targted Drug market size growth rate in several scenarios, and the measures to be undertaken by Small Molecule Anti-tumor Targted Drug companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
EGFR
ALK
Bcr-Abl
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Astrazeneca
Bristol-Myers Squibb
Novartis
Bayer
Exelixis
Millennium Pharmaceuticals
Eisai
Abbvie
Pfizer
Boehringer-Ingelheim
Roche
Bettapharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Small Molecule Anti-tumor Targted Drug market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Small Molecule Anti-tumor Targted Drug market by identifying its various subsegments.
Focuses on the key global Small Molecule Anti-tumor Targted Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Small Molecule Anti-tumor Targted Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Small Molecule Anti-tumor Targted Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Small Molecule Anti-tumor Targted Drug Market Size 2015-2025
2.1.2 Small Molecule Anti-tumor Targted Drug Market Size CAGR by Region
2.2 Small Molecule Anti-tumor Targted Drug Segment by Type
2.2.1 EGFR
2.2.2 EGFR
2.2.3 Bcr-Abl
2.2.4 Others
2.3 Small Molecule Anti-tumor Targted Drug Market Size by Type
2.3.1 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)
2.3.2 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type (2015-2020)
2.4 Small Molecule Anti-tumor Targted Drug Segment by Application
2.4.1 Liver Cancer
2.4.2 Colorectal Cancer
2.4.3 Lung Cancer
2.4.4 Gastric Cancer
2.4.5 Breast Cancer
2.4.6 Esophageal Cancer
2.4.7 Others
2.5 Small Molecule Anti-tumor Targted Drug Market Size by Application
2.5.1 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)
2.5.2 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Application (2015-2020)
3 Global Small Molecule Anti-tumor Targted Drug by Players
3.1 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Players
3.1.1 Global Small Molecule Anti-tumor Targted Drug Market Size by Players (2018-2020)
3.1.2 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Players (2018-2020)
3.2 Global Small Molecule Anti-tumor Targted Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Small Molecule Anti-tumor Targted Drug by Regions
4.1 Small Molecule Anti-tumor Targted Drug Market Size by Regions
4.2 Americas Small Molecule Anti-tumor Targted Drug Market Size Growth
4.3 APAC Small Molecule Anti-tumor Targted Drug Market Size Growth
4.4 Europe Small Molecule Anti-tumor Targted Drug Market Size Growth
4.5 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Growth
5 Americas
5.1 Americas Small Molecule Anti-tumor Targted Drug Market Size by Countries
5.2 Americas Small Molecule Anti-tumor Targted Drug Market Size by Type
5.3 Americas Small Molecule Anti-tumor Targted Drug Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Small Molecule Anti-tumor Targted Drug Market Size by Regions
6.2 APAC Small Molecule Anti-tumor Targted Drug Market Size by Type
6.3 APAC Small Molecule Anti-tumor Targted Drug Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Small Molecule Anti-tumor Targted Drug by Countries
7.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type
7.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug by Countries
8.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type
8.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Small Molecule Anti-tumor Targted Drug Market Forecast
10.1 Global Small Molecule Anti-tumor Targted Drug Market Size Forecast (2021-2025)
10.2 Global Small Molecule Anti-tumor Targted Drug Forecast by Regions
10.2.1 Global Small Molecule Anti-tumor Targted Drug Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Small Molecule Anti-tumor Targted Drug Forecast by Type
10.8 Global Small Molecule Anti-tumor Targted Drug Forecast by Application
11 Key Players Analysis
11.1 Astrazeneca
11.1.1 Company Details
11.1.2 Small Molecule Anti-tumor Targted Drug Product Offered
11.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Astrazeneca News
11.2 Bristol-Myers Squibb
11.2.1 Company Details
11.2.2 Small Molecule Anti-tumor Targted Drug Product Offered
11.2.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Bristol-Myers Squibb News
11.3 Novartis
11.3.1 Company Details
11.3.2 Small Molecule Anti-tumor Targted Drug Product Offered
11.3.3 Novartis Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Novartis News
11.4 Bayer
11.4.1 Company Details
11.4.2 Small Molecule Anti-tumor Targted Drug Product Offered
11.4.3 Bayer Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Bayer News
11.5 Exelixis
11.5.1 Company Details
11.5.2 Small Molecule Anti-tumor Targted Drug Product Offered
11.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Exelixis News
11.6 Millennium Pharmaceuticals
11.6.1 Company Details
11.6.2 Small Molecule Anti-tumor Targted Drug Product Offered
11.6.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Millennium Pharmaceuticals News
11.7 Eisai
11.7.1 Company Details
11.7.2 Small Molecule Anti-tumor Targted Drug Product Offered
11.7.3 Eisai Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Eisai News
11.8 Abbvie
11.8.1 Company Details
11.8.2 Small Molecule Anti-tumor Targted Drug Product Offered
11.8.3 Abbvie Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Abbvie News
11.9 Pfizer
11.9.1 Company Details
11.9.2 Small Molecule Anti-tumor Targted Drug Product Offered
11.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Pfizer News
11.10 Boehringer-Ingelheim
11.10.1 Company Details
11.10.2 Small Molecule Anti-tumor Targted Drug Product Offered
11.10.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Boehringer-Ingelheim News
11.11 Roche
11.12 Bettapharma
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Small Molecule Anti-tumor Targted Drug Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of EGFR
Table 5. Major Players of ALK
Table 6. Major Players of Bcr-Abl
Table 7. Major Players of Others
Table 8. Small Molecule Anti-tumor Targted Drug Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)
Table 10. Global Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)
Table 12. Global Small Molecule Anti-tumor Targted Drug Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Players (2018-2020)
Table 14. Global Small Molecule Anti-tumor Targted Drug Key Players Head office and Products Offered
Table 15. Small Molecule Anti-tumor Targted Drug Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Small Molecule Anti-tumor Targted Drug Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Regions 2015-2020
Table 20. Americas Small Molecule Anti-tumor Targted Drug Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries (2015-2020)
Table 22. Americas Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)
Table 24. Americas Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)
Table 26. APAC Small Molecule Anti-tumor Targted Drug Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Regions (2015-2020)
Table 28. APAC Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)
Table 30. APAC Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)
Table 32. Europe Small Molecule Anti-tumor Targted Drug Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries (2015-2020)
Table 34. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)
Table 36. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Small Molecule Anti-tumor Targted Drug
Table 45. Key Application and Potential Industries of Small Molecule Anti-tumor Targted Drug
Table 46. Key Challenges of Small Molecule Anti-tumor Targted Drug
Table 47. Key Trends of Small Molecule Anti-tumor Targted Drug
Table 48. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share Forecast by Regions
Table 50. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share Forecast by Application (2021-2025)
Table 54. Astrazeneca Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 55. Astrazeneca Small Molecule Anti-tumor Targted Drug Product Offered
Table 56. Astrazeneca Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)
Table 57. Astrazeneca Main Business
Table 58. Astrazeneca Latest Developments
Table 59. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 60. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Offered
Table 61. Bristol-Myers Squibb Main Business
Table 62. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)
Table 63. Bristol-Myers Squibb Latest Developments
Table 64. Novartis Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 65. Novartis Small Molecule Anti-tumor Targted Drug Product Offered
Table 66. Novartis Main Business
Table 67. Novartis Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)
Table 68. Novartis Latest Developments
Table 69. Bayer Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 70. Bayer Small Molecule Anti-tumor Targted Drug Product Offered
Table 71. Bayer Main Business
Table 72. Bayer Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)
Table 73. Bayer Latest Developments
Table 74. Exelixis Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 75. Exelixis Small Molecule Anti-tumor Targted Drug Product Offered
Table 76. Exelixis Main Business
Table 77. Exelixis Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)
Table 78. Exelixis Latest Developments
Table 79. Millennium Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 80. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Offered
Table 81. Millennium Pharmaceuticals Main Business
Table 82. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)
Table 83. Millennium Pharmaceuticals Latest Developments
Table 84. Eisai Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 85. Eisai Small Molecule Anti-tumor Targted Drug Product Offered
Table 86. Eisai Main Business
Table 87. Eisai Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)
Table 88. Eisai Latest Developments
Table 89. Abbvie Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 90. Abbvie Small Molecule Anti-tumor Targted Drug Product Offered
Table 91. Abbvie Main Business
Table 92. Abbvie Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)
Table 93. Abbvie Latest Developments
Table 94. Pfizer Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 95. Pfizer Small Molecule Anti-tumor Targted Drug Product Offered
Table 96. Pfizer Main Business
Table 97. Pfizer Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)
Table 98. Pfizer Latest Developments
Table 99. Boehringer-Ingelheim Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 100. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Offered
Table 101. Boehringer-Ingelheim Main Business
Table 102. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Revenue and Gross Margin (2018-2020E)
Table 103. Boehringer-Ingelheim Latest Developments
Table 104. Roche Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
Table 105. Bettapharma Details, Company Total Revenue (in $ million), Head Office, Small Molecule Anti-tumor Targted Drug Major Market Areas and Its Competitors
List of Figures
Figure 1. Small Molecule Anti-tumor Targted Drug Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2015-2020)
Figure 5. Global EGFR Market Size Growth Rate
Figure 6. Global ALK Market Size Growth Rate
Figure 7. Global Bcr-Abl Market Size Growth Rate
Figure 8. Global Others Market Size Growth Rate
Figure 9. Small Molecule Anti-tumor Targted Drug in Liver Cancer
Figure 10. Global Small Molecule Anti-tumor Targted Drug Market: Liver Cancer (2015-2020) ($ Millions)
Figure 11. Small Molecule Anti-tumor Targted Drug in Colorectal Cancer
Figure 12. Global Small Molecule Anti-tumor Targted Drug Market: Colorectal Cancer (2015-2020) ($ Millions)
Figure 13. Small Molecule Anti-tumor Targted Drug in Lung Cancer
Figure 14. Global Small Molecule Anti-tumor Targted Drug Market: Lung Cancer (2015-2020) ($ Millions)
Figure 15. Global Lung Cancer YoY Growth ($ Millions)
Figure 16. Small Molecule Anti-tumor Targted Drug in Gastric Cancer
Figure 17. Global Small Molecule Anti-tumor Targted Drug Market: Gastric Cancer (2015-2020) ($ Millions)
Figure 18. Global Gastric Cancer YoY Growth ($ Millions)
Figure 19. Small Molecule Anti-tumor Targted Drug in Breast Cancer
Figure 20. Global Small Molecule Anti-tumor Targted Drug Market: Breast Cancer (2015-2020) ($ Millions)
Figure 21. Global Breast Cancer YoY Growth ($ Millions)
Figure 22. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2019
Figure 23. Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Regions 2015-2020
Figure 24. Americas Small Molecule Anti-tumor Targted Drug Market Size 2015-2020 ($ Millions)
Figure 25. APAC Small Molecule Anti-tumor Targted Drug Market Size 2015-2020 ($ Millions)
Figure 26. Europe Small Molecule Anti-tumor Targted Drug Market Size 2015-2020 ($ Millions)
Figure 27. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size 2015-2020 ($ Millions)
Figure 28. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries in 2019
Figure 29. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2019
Figure 30. Americas Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2019
Figure 31. United States Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 32. Canada Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 33. Mexico Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 34. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Regions in 2019
Figure 35. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2019
Figure 36. APAC Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2019
Figure 37. China Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 38. Japan Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 39. Korea Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 40. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 41. India Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 42. Australia Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 43. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries in 2019
Figure 44. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2019
Figure 45. Europe Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2019
Figure 46. Germany Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 47. France Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 48. UK Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 49. Italy Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 50. Russia Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 51. Spain Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 52. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Countries in 2019
Figure 53. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type in 2019
Figure 54. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size Market Share by Application in 2019
Figure 55. Egypt Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 56. South Africa Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 57. Israel Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 58. Turkey Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 59. GCC Countries Small Molecule Anti-tumor Targted Drug Market Size Growth 2015-2020 ($ Millions)
Figure 60. Global Small Molecule Anti-tumor Targted Drug arket Size Forecast (2021-2025) ($ Millions)
Figure 61. Americas Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 62. APAC Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 63. Europe Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 64. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 65. United States Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 66. Canada Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 67. Mexico Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 68. Brazil Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 69. China Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 70. Japan Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 71. Korea Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 72. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 73. India Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 74. Australia Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 75. Germany Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 76. France Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 77. UK Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 78. Italy Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 79. Russia Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 80. Spain Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 81. Egypt Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 82. South Africa Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 83. Israel Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 84. Turkey Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
Figure 85. GCC Countries Small Molecule Anti-tumor Targted Drug Market Size 2021-2025 ($ Millions)
